Clinical Trials Directory

Trials / Completed

CompletedNCT00742430

Resistance on Antithrombotic Drugs in Ischemic Heart Disease

Assessment of Aspirin and Clopidogrel Resistance in Ischemic Heart Disease Using Multiplate Function Analyser and it's Correlation With Major Adverse Cardiac Events

Status
Completed
Phase
Study type
Observational
Enrollment
141 (actual)
Sponsor
University of Zagreb · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether aspirin and clopidogrel resistance measured with Multiplate function analyser has a good correlation with incidence of major adverse cardiac events in patients with coronary artery disease (CAD).

Detailed description

Our plan is to enroll 180 patients with diagnosed CAD who electively undergo percutaneous coronary intervention (PCI). Blood samples will be taken just before the procedure and one day after the procedure and analysed on Multiplate function analyser. Assessing aspirin and clopidogrel resistance incidence using Multiplate platelet function analyzer we will also try to find resistance correlation with the incidence of major adverse cardiac events in a one year follow up.

Conditions

Interventions

TypeNameDescription
PROCEDUREPCIpercutaneous coronary intervention in stable coronary artery disease

Timeline

Start date
2009-02-01
Completion
2011-08-01
First posted
2008-08-27
Last updated
2012-02-14

Locations

1 site across 1 country: Croatia

Source: ClinicalTrials.gov record NCT00742430. Inclusion in this directory is not an endorsement.